Joseph P. Hagan, CEO: Regulus Therapeutics RGLS Sell · Filed 24/01/18

Trade details

Type: Insider sale
Amount: $17,350.2
Shares · price: 14,580 sh · $1.19 a share
Held after: 57,112 sh
Stock: Regulus Therapeutics RGLS
Person: Joseph P. HaganCEO
Trade date: 24/01/18
Filed: 24/01/18
Days to filing: 0 days

Sold 20.3% of holdings

Share of holding sold: 20.3%

Regulus Therapeutics trades, last 26 weeks

What else happened in Regulus Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/19~24/02/17

Joseph P. Hagan's recent trades

Joseph P. HaganCEO
BuyRegulus Therapeutics
Buy
Regulus Therapeutics
RGLS
$54.5K
50,000 sh
$54.5K
Filed 25/01/31
Traded 25/01/30
Joseph P. HaganCEO
Sell10b5-1 planRegulus Therapeutics
Sell10b5-1 plan
Regulus Therapeutics
RGLS
$145.3K
115,290 sh
$145.3K
Filed 25/01/15
Traded 25/01/13
Joseph P. HaganCEO
Sell10b5-1 planRegulus Therapeutics
Sell10b5-1 plan
Regulus Therapeutics
RGLS
$14.8K
11,764 sh
$14.8K
Filed 25/01/15
Traded 25/01/14
Joseph P. HaganDirector
SellAurinia Pharmaceuticals
Sell
Aurinia Pharmaceuticals
AUPH
$2,878
272 sh
$2,878
Filed 23/05/23
Traded 23/05/19